Phase II Clinical Trials These promising preclinical findings led to Phase I and Phase II clinical trials in humans
In a RCT involving 120 patients with mild gut inflammation, an 8-week inulin intervention resulted in a 32.6% reduction in fecal calprotectin, a recognized biomarker of gut inflammation (124)
Funding This research was supported by the Arkansas Biosciences Institute (Little Rock, AR, USA), The Jonty Foundation (St Paul, MN), The Autism Research Institute (San Diego, CA), the Gupta Family Foundation (Atherton, CA), The Jane Bostford Johnson Foundation (New York, NY) and the Jager Family Foundation (Chicago, IL)
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
Experienced customer service who answers the phone could always solve problem efficiently
Semaglutide and other GLP-1 medications have turned the tide in the battle against obesity